Showing results (1751-1760 of 1,960) with videos related to

Sort By:
Pageof 196
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2012
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologistsMoniek W M van de Luijtgaarden, Marlies Noordzij, Charles Tomson, et al.
The Journal of Clinical Investigation|April 28, 2023
iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial functionKevin T Eade, Brendan Robert E Ansell, Sarah Giles, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 1, 2021
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional ExperienceN Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Bone Marrow Transplantation|May 4, 2010
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilizationH V Naina, R K Pruthi, D J Inwards, et al.
Blood|February 6, 2014
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical featuresTianjiao Wang, Andrew L Feldman, David A Wada, et al.
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Investigational New Drugs|January 10, 2018
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancerDiane A J van der Biessen, Jourik A Gietema, Maja J A de Jonge, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
The New England Journal of Medicine|December 9, 2014
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphomaStephen M Ansell, Alexander M Lesokhin, Ivan Borrello, et al.
Cancer Causes & Control : CCC|May 1, 2012
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphomaJennifer L Kelly, Matthew T Drake, Zachary S Fredericksen, et al.
Pageof 196